AKT1 and lip and oral cavity carcinoma: In oral cancer cells, the miR-34a-5p/AXL axis increased aggressiveness and could be a therapeutic target for OSCC by affecting AKT, GSK-3, β-catenin, and Snail signaling (Fig. 1) [65].